Aluminium hydroxide 4-(carbamoylamino)-5-oxo-4,5-dihydro-1H-imidazol-2-olate (1:2:1)(CAS: 5579-81-7)

Aluminium hydroxide 4-(carbamoylamino)-5-oxo-4,5-dihydro-1H-imidazol-2-olate (CAS: 5579-81-7) is subject to various regulatory guidelines. Under GHS, it is classified based on its physical and health hazards. For manufacturing and import/export, REACH regulations require registration if it meets the tonnage threshold. FDA and EPA have specific regulations for its use in pharmaceuticals and environmental releases, respectively.

Several alternatives can be used in the synthesis of Aluminium hydroxide 4-(carbamoylamino)-5-oxo-4,5-dihydro-1H-imidazol-2-olate (CAS: 5579-81-7). Common alternatives include isomers of related compounds, such as other imidazol-2-olates, and analogs like 5-aminomethyl-1H-imidazol-2-olate. Substitutes like 1,2-bis(4-aminophenyl)ethane can also serve as effective reagents.

The market for Aluminium hydroxide 4-(carbamoylamino)-5-oxo-4,5-dihydro-1H-imidazol-2-olate (CAS: 5579-81-7) is driven by its applications in pharmaceuticals and industrial catalysts. Research trends focus on its use as a chelating agent and in drug delivery systems. Emerging studies are exploring its potential in water purification and as a biodegradable material, reflecting increasing interest in sustainable chemistry.

Waste containing Aluminium hydroxide 4-(carbamoylamino)-5-oxo-4,5-dihydro-1H-imidazol-2-olate (CAS: 5579-81-7) should be managed in accordance with local and international environmental regulations. Waste liquid should be collected in leak-proof containers and disposed of through incineration or professional waste disposal services. For solid waste, ensure it is packaged safely and transported to licensed facilities. Always follow the GHS guidelines for handling hazardous materials.